These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14174592)

  • 21. THE EFFECT OF COPPER IONS ON CLOT LYSIS TIME IN THE FIBRINOLYTIC ASSAY OF STREPTOKINASE.
    BOGERT AB
    Thromb Diath Haemorrh; 1965 Jun; 13():477-83. PubMed ID: 14347869
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON THE COAGULATION AND FIBRINOLYTIC SYSTEM IN LETHALLY IRRADIATED DOGS.
    WEGRZYNOWICZ Z; KOPEC M; LATALLO Z; KOWALSKI E
    Arch Immunol Ther Exp (Warsz); 1964; 12():524-33. PubMed ID: 14252035
    [No Abstract]   [Full Text] [Related]  

  • 23. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 24. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

  • 25. [ON THE MECHANISM OF ACTION OF FIBRINOLYTIC SUBSTANCES].
    ROSOLLECK H
    Thromb Diath Haemorrh; 1963 Jul; 143():459-71. PubMed ID: 14081267
    [No Abstract]   [Full Text] [Related]  

  • 26. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of intravenously administered streptokinase on fibrinolysis and blood coagulation].
    DEUTSCH E; FISCHER M
    Thromb Diath Haemorrh; 1960 Jun; 4():482-506. PubMed ID: 13816260
    [No Abstract]   [Full Text] [Related]  

  • 28. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE.
    JOHNSON AJ; NEWMAN J
    Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683
    [No Abstract]   [Full Text] [Related]  

  • 29. FIBRINOLYSIS AND FIBRINOGEN BREAKDOWN PRODUCTS (ANTITHROMBIN VI) IN RENAL VENOUS BLOOD (RVB) IN DOG.
    WOROWSKI K; NIEWIAROWSKI S; PROKOPOWICZ J
    Thromb Diath Haemorrh; 1964 Oct; 12():87-104. PubMed ID: 14224648
    [No Abstract]   [Full Text] [Related]  

  • 30. THE INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON THE LAST STAGE OF COAGULATION.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():327-30. PubMed ID: 14073280
    [No Abstract]   [Full Text] [Related]  

  • 31. [FIBRINOLYSIS, THROMBOLYSIS AND FIBRINOLYTIC TREATMENT].
    STOICHITA M
    Med Interna (Bucur); 1964 Oct; 16():1163-72. PubMed ID: 14244194
    [No Abstract]   [Full Text] [Related]  

  • 32. ULTRASONIC MEASUREMENT OF COAGULATION AND FIBRINOLYSIS.
    PEETERS H; STEENHOUDT G; DECROIX G
    J Clin Pathol; 1964 May; 17(3):320-3. PubMed ID: 14159472
    [No Abstract]   [Full Text] [Related]  

  • 33. [TECHNIC FOR THE PREPARATION OF A FIBRINOGEN REAGENT FOR DETERMINATIONS OF FIBRINOLYTIC ACTIVITY].
    BLATRIX C; VIGNAL A; STEINBUCH M
    Hemostase; 1963; 3():179-86. PubMed ID: 14050814
    [No Abstract]   [Full Text] [Related]  

  • 34. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 35. [LABORATORY CONTROL OF THROMBOLYTIC THERAPY].
    OSTEN W
    Med Lab (Stuttg); 1964 Feb; 17():42-5. PubMed ID: 14151272
    [No Abstract]   [Full Text] [Related]  

  • 36. THROMBOLYSIS STUDIED IN AN ARTIFICIAL CIRCULATION: THROMBI PREPARED IN VITRO IN A CHANDLER'S TUBE.
    MCNICOL GP; BAIN WH; WALKER F; RIFKIND BM; DOUGLAS AS
    Lancet; 1965 Apr; 1(7390):838-42. PubMed ID: 14263541
    [No Abstract]   [Full Text] [Related]  

  • 37. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
    CLIFFTON EE
    Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024
    [No Abstract]   [Full Text] [Related]  

  • 38. [PRESENT STATUS OF THROMBOLYTIC THERAPY].
    VAIREL EG; ANTOINE G
    Sangre (Barc); 1964; 41():441-6. PubMed ID: 14248832
    [No Abstract]   [Full Text] [Related]  

  • 39. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
    AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
    Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
    [No Abstract]   [Full Text] [Related]  

  • 40. [ON THE FIBRINOLYTIC ACTIVITY OF ERYTHROCYTES IN MAN AND VARIOUS ANIMALS].
    KUENZER W; HABERHAUSEN D
    Klin Wochenschr; 1963 Aug; 41():831-4. PubMed ID: 14045598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.